Massive stroke trial aims to cut deadly delays in china

NCT ID NCT07135310

Recruiting now Knowledge-focused Sponsor: Shanghai Minhang Central Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This trial tests whether a community education and training campaign can reduce the time it takes for stroke patients to get to the hospital. Over 1.6 million people in 16 communities across China will be involved. The goal is to increase the number of patients arriving within the critical 4.5-hour window for treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: STROKE 120 multifaceted intervention campaign (training medical workers, emergency staff, and public education)
What this could lead to: If successful, this campaign could significantly reduce the time it takes for stroke patients to reach the hospital, potentially improving survival and reducing disability.
What could go wrong: This is a behavioral intervention, not a drug, so results depend on community engagement. The trial is large but still early, and success in China may not directly apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE

Contacts and locations

Show contact details

Locations

Shanghai Minhang Central Hospital
RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.